ArticleTherapeutic advances in medical oncology2022

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia.

Jia Li Low et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.